Structure of the rat pro-opiomelanocortin (POMC) gene  by Drouin, Jacques et al.
Volume 193, number 1 FEBS 3144 November 1985 
Structure of the rat pro-opiomelanocortin (POMC) gene 
Jacques Drouin, Michel Chamberland, Jean Charron, Lucie Jeannotte and Mona Nemer 
Laboratoire de Biologie MolPculaire des Eucaryotes, Institut de recherches cliniques de Montrtal, 110 ouest. Avenue des 
Pins, MontrPal, Qutbec HZ W 1 R7. Canada 
Received 3 1 August 1985 
The gene encoding pro-opiomelanocortin (POMC) presents unique regulatory features. In particular, gluco- 
corticoids inhibit transcription of the POMC gene in the anterior pituitary, but not in the intermediate pitu- 
itary. In order to study the mechanism leading to transcriptional inhibition of POMC by glucocorticoid 
and the interaction of the glucocorticoid receptor complex with specific DNA sequences along the POMC 
gene, we have cloned the rat POMC gene and determined its structure. The gene is composed of three exons 
and appears to be present at a single copy per haploid genome. Besides the usual regulatory signals like 
‘TATA’ and ‘CCAAT’ boxes, the upstream region contains sequences homologous to known enhancer se- 
quences and to the glucocorticoid receptor binding site observed in glucocorticoid-responsive genes. 
Pro-opiomelanocortin DNA sequence Gene structure 
1. INTRODUCTION 
Pro-opiomelanocortin (POMC) is the protein 
precursor to a variety of active hormonal peptides; 
they include adrenocorticotropin (ACTH), p- 
endorphin, P-lipotropin (B-LPH), and the melano- 
tropins (a, ,&, y-MSH) [1,2]. POMC mRNA is 
found in the anterior and intermediate lobes of the 
pituitary, in certain areas of the brain like the 
hypothalamus, the amygdala and the cortex, in the 
testes, ovaries, placenta, and in a variety of tumors 
[3-71. POMC is differentially processed in the 
pituitary: ACTH and ,&LPH are the major pro- 
cessing products in the anterior lobe whereas a- 
MSH and &endorphin are more abundant in the 
intermediate pituitary [l]. The release of POMC- 
derived peptides from the pituitary is under multi- 
hormonal control [8]. In the anterior but not in the 
intermediate pituitary, glucocorticoids inhibit 
POMC gene transcription [9-l I]; corticoliberin 
(CRF) stimulate POMC gene transcription [ll]. 
Thus, the POMC gene is an interesting model 
system to study negative regulation of transcrip- 
tion by steroid hormones. We have reported the 
DNA sequence of the third exon of the rat POMC 
gene containing most of the coding sequences [ 121. 
We now report the complete structure of the gene 
and DNA sequences around all 3 exons including 
711 base pairs (bp) upstream of the site of initia- 
tion of transcription. The upstream DNA sequence 
will be useful to study by surrogate genetics the 
regulation of POMC gene transcription. 
2. MATERIALS AND METHODS 
Standard cloning techniques were used [ 131. A 
rat genomic DNA library was constructed in 
bacteriophage h 1059 [14]. Genomic DNA was 
isolated from Sprague-Dawley rat livers and par- 
tially digested with Sau3A. The DNA was size- 
fractionated on agarose gel and the 18-22 kb frac- 
tion was ligated with BamHI-digested X 1059 DNA. 
A library containing 1.4 x lo6 recombinant phages 
was obtained and screened by hybridization with a 
nick-translated 1.6 kb XhoI-Hind111 fragments 
containing the third exon of rPOMC [12]. Primer 
extension was performed as in [ 151. DNA sequenc- 
ing was carried out by the procedure of Sanger et 
al. [16], using Ml3 single-stranded DNA templates, 
and Maxam and Gilbert 1171. 
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3. RESULTS AND DISCUSSION 
The complete POMC gene was isolated from a 
Sprague-Dawley rat genomic DNA library cloned 
in bacteriophage h1059. A 1.6 kb X&I-HindIf 
genomic DNA fragment containing the third exon 
of rPUMC f12f was used as probe. Four indepen- 
dent clones were isolated and characterized by 
restriction enzyme mapping. Two of these contain 
more than 6 kb upstream of previously reported 
rPOMC sequences [12]. All 4 clones have similar 
restriction maps when compared with each other 
and with 3 previously characterized rPOMC clones 
isolated from a Long-Evans rat genomic DNA 
library [12]. Fragments from the A clones were 
subcloned in pBR327 to facilitate analysis. Exons 
1 and 2 were localized by hybridization with a 
DNA probe (about 370 bp) made by primer exten- 
sion on neurointermediate pituitary polyyfA’) RNA 
using a 118 bp Ha&II fragment as primer (en- 
coding amino acids 23-62 of POMC). Fig.1 il- 
lustrates the structure of the rPOMC gene: the 
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Fig. 1. Structure of rat POMC gene. (a) Rat genamie DNA restriction map. Restriction enzyme cIeavage sites: EcoRI 
(J-r, HindHI (?I, XbaI ( 7 ), WI1 (A ), PstI ( i ), BarnHI (A ), Accf ( J: ). HpaI (y )* X&oI ( y ), K@I (f)‘ PO&K exon 
sequences are indicated by solid boxes on the restriction map; a schematic digram of rPOMC mRNA shows regions 
present in each exon. ‘The translated portion of the mRNA is shown as an open box. (b,c) Strategy used for DNA se- 
quence determination of exons 1 and 2, respectively. Arrows below the diagrams indicate the length and direction of 
sequence determination. Symbols as in a; and XmnI ( f), StuI (t), ApaI ( 7). 
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restriction enzyme cleavage map is shown together 
with the position and size of exon sequences. The 
rPOMC gene spans about 6 kb and is divided in 3 
exons like the human [ 18-211, bovine [22] and 
mouse [23,24] POMC genes. The first and second 
introns are about 3 and 1.8 kb in size, respectively. 
Repeated sequences are present in the first intron 
within the 1 kb Hind111 fragment as both this 1 kb 
IiindIII fragment and the overlapping 2 kb BarnHI 
fragment, but not the 1.6 kb BumHI-Hind111 frag- 
ment, hybridize to a smear in rat genomic DNA 
blots. Analysis by Southern blotting of rat genomic 
DNA isolated from various sources (Iivers of 
Sprague-Dawley, Long-Evans and NEDH rats, 
CH3 (Wistar-Furth rat) and HTC (buffalo rat 
cells) suggests the cloned gene is unique (not 
shown). The discrepancy between these results and 
previous ones is due to contaminating plasmid 
DNA present in the genomic DNA preparation 
used in [12]. 
The DNA sequence of regions containing exons 
1 and 2 was determined by the dideoxy chain ter- 
mination method after subcloning appropriate 
fragments in bacteriophage Ml3 mp8 and mp9 
[ 151. The sequencing strategy is indicated by ar- 
rows in fig.lb and c. The sequenced DNA (fig.2) 
includes 711 bp in the 5 ‘-flanking region which 
might contain important regulatory sequences. 
The exon-intron borders were assigned by com- 
parison with a rat neurointermediate pituitary 
cDNA clone obtained in this laboratory; this 
cDNA clone includes the 2 exon-intron junctions 
and contains the last 21 bp of exon 1. Oates and 
Herbert 1251 obtained a rat POMC mRNA se- 
quence by specific priming on pituitary poly(A+) 
RNA: both sequences agree except for the codon 
for amino acid -21. A Tyr residue is also found at 
that position in mouse POMC [23,24], like in our 
rPOMC sequence. Oates and Herbert [25] also 
Fig.2. DNA sequence of the rat POMC gene. Intron sequences are shown in lower case. Amino acids are numbered 
positively for POMC and negatively for the signal peptide sequence. Similarly, nucleotides are numbered positively 
downstream from the site of transcription initiation {CAP) and negatively upstream. The TATA box and 3 putative 
CCAAT boxes are boxed. The alternate splice points used in pituitary [25] are shown at the 5’-end of exon 2. The exon 
3 sequence is as in [12]; however, sequence analysis of a Sprague-Dawley rat cDNA indicates a difference at codon 204 
of POMC between this strain and Long-Evans rat as reported [12]. 
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characterized a POMC mRNA produced by alter- 
nate splicing: the additional 30 bp segment present 
in this mRNA is found at the 3 ‘-end of intron A. 
The site of initiation of transcription (CAP in 
fig.2) was assigned on the basis of our primer- 
extension studies, of those of Oates and Herbert 
1251 and by comparison with the human, bovine 
and mouse POMC genes [ 18-241. 
A perfect TATAAA sequence is found 30 bp 
upstream of the site of transcription initiation. 
Three sequences homologous to the GGfCAATCT 
consensus are found between -67 and -47 bp. Such 
sequences were shown to be important in determin- 
ing the site and efficiency of transcription initia- 
tion, respectively 1261. Enhancer sequences play an 
important role in transcriptional activation and, in 
some cases, confer tissue specificity [26-281. Se- 
quences homologous (7/8) to the SV40-type core 
consensus enhancer sequence [27], GTGG$t$G, 
are found at -357, -246, -188 and +85 bp. In addi- 
tion, sequences homologous (8/10) to another 
enhancer consensus characterized initially in 
adenovirus [28] are found at -257 and -66 and +14 
bp. Interestingly, SV40 and adenovirus-type con- 
sensus sequences are contiguous at positions -257 
and -246 bp; they are both in opposite orientation 
to transcription. Two similar sequences are also 
found cIose to each other (9 bp away) upstream of 
the rat growth hormone gene at positions -193 and 
- 176 129,301; in this case, they are both in the 
same orientation as transcription. The hexanu- 
cleotide sequence CCGCCC present in the SV40 21 
bp repeats and known region (-145 to - 118 bp) 
containing asymetrically distributed purines and 
pyrimidines. Sequences containing alternating 
purine-pyrimidine and having the potential to take 
the Z-DNA conformation could also contribute to 
transcriptiona control [32,33]; such sequences are 
found at -369, -229 and -170 bp in rPOMC. 
Transcription of the rPOMC gene is inhibited by 
glucocorticoids and stimulated by CRF and cyclic 
AMP ([13]; Gagner and Drouin, submitted). 
Glucocorticoid action is thought to be mediated by 
binding of the steroid to the glucocorticoid recep- 
tor protein. If the hormone-r~eptor complex acts 
directly at the DNA level to inhibit transcription, 
it could bind to sites homologous to those de- 
scribed in mouse mammary tumor virus (MMTV) 
134,351. The rPOMC 5 ‘-flanking and exon 1 se- 
quences do not contain the hexanucleotide se- 
quence TGTYCT found in previously described 
glucocorticoid receptor binding sites [34-361; 
however, many (11) homologous sequences are 
present. Some are found in exon 1 and in near 
upstream sequences: receptor binding in this 
region could inhibit transcription because of com- 
petition at overlapping binding sites for transcrip- 
tional factor(s). One hexanucleotide sequence 
(-589 bp) has more extensive homology with a con- 
sensus derived by comparison of binding sites in 
MMTV, human metallothionein II.4 and rabbit 
uteroglobin [36]. Experiments are underway to test 
for glucocorticoid receptor binding in this region 
and for glucocorticoid responsiveness in gene 
transfer experiments. 
ACKNOWLEDGEMENTS 
We are grateful to Guy Page, Barbara Cordell, 
Don Diamond and Keith Yamamoto for Long- 
Evans, NEDH, GH3 and HTC genomic DNA, 
respectively. We thank Mamdouh Mikhail for help 
in computer sequence analysis and Diane Lapointe 












Eipper, B. and Mains, R. (1982) Endocr. Rev. 1, 
l-27. 
Nakanishi, S., Inoue, A., Kita, T., Nakamura, M., 
Chang, A.C.Y., Cohen, S.N. and Numa, S. (1979) 
Nature 278, 423-427. 
Civelli, O., Birnberg, N. and Herbert, E. (1982) J. 
Biol. Chem. 257, 6783-6787. 
Gee, C.E., Chen, C.-L.C. and Roberts, J.L. (1983) 
Nature 306, 374-376. 
Chen, C.-L.C., Mather, J.P., Morris, P.L. and 
Bardin, W. (1984) Proc. Natl. Acad. Sci. USA 81, 
5672-5675. 
Chen, C.-L.C. and Chang, C.-C. (1985) Proc. 67th 
Annual Meeting Endocrine Society, 161. 
De Bold, C.R., Schworer, M.E., Connor, T.B., 
Bird, R.E. and Orth, D.N. (1983) Science 220, 
721-723. 
Vale, W., Vaughan, J., Smith, M., Yamamoto, G., 
Rivier, J. and Rivier, C. (1983) Endocrinology 113, 
1121-l 131. 
Birnberg, N.C., Lissitzky, J.C., Hinman, M. and 
Herbert, E. (1983) Proc. NatI. Acad. Sci. USA 80, 
6982-6986. 
Eberwine, J.H. and Roberts, J.L. (1984) J. Biol. 
Chem. 259, 21662170. 
57 
Volume 193, number 1 FEBS LETTERS November 1985 
[ll] Gagner, J.P. and Drouin, J. (1985) Mol. Cell. 
Endocrinol. 40, 25-32. 
[12] Drouin, J. and Goodman, H.M. (1980) Nature 288, 
610-613. 
[24] Uhler, M., Herbert, E., D’Eustachio, P. and 
Ruddle, D. (1983) J. Biol. Chem. 258, 9444-9453. 
[25] Oates, E. and Herbert, E. (1984) J. Biol. Chem. 
259, 7421-7425. 
[13] Maniatis, T., Fritsch, E.F. and Sambrook, J. 
(1982) Molecular CLoning, Cold Spring Harbor 
Laboratory, Cold Spring Harbor, NY. 
[14] Karn, J., Brenner, S., Barnett, L. and Cesareni, G. 
(1980) Proc. Natl. Acad. Sci. USA 77, 5172-5176. 
[15] Nemer, M., Chamberland, M., Sirois, D., Argentin, 
S., Drouin, J., Dixon, R.A., Zivin, R.A. and 
Condra, J. (1984) Nature 312, 654-656. 
[16] Sanger, F., Nicklen, S. and Coulson, A.R. (1977) 
Proc. Natl. Acad. Sci. USA 74, 5463-5469. 
[17] Maxam, A.M. and Gilbert, W. (1977) Proc. Natl. 
Acad. Sci. USA 74, 560-564. 
[18] Takahashi, H., Teranishi, Y., Nakanishi, S. and 
Numa, S. (1981) FEBS Lett. 135, 97-102. 
[19] Cachet, M., Chang, A.C.Y. and Cohen, S.N. 
(1982) Nature 297, 335-339. 
[20] Whitfeld, P.L., Seeburg, P.H. and Shine, S. (1982) 
DNA 1, 133-143. 
[26] Chambon, P., Dierich, A., Gaub, M.P., Jakowlev, 
S., Jongstra, J., Krust, A., LePennec, J.P., Oudet, 
P. and Reudelhuber, T. (1984) Recent Prog. Horm. 
Res. 40, l-42. 
[27] Weiher, H., Konig, M. and Gruss, P. (1983) 
Science 219, 626-631. 
[28] Hearing, P. and Shenk, T. (1983) Cell 33, 695-703. 
[29] Barta, A., Richards, R.I., Baxter, J.D. and Shine, 
J. (1981) Proc. Natl. Acad. Sci. USA 78,4867-4871. 
[30] Page, G.S., Smith, S. and Goodman, G.M. (1981) 
Nucleic Acid Res. 9, 2087-2104. 
[31] Gidoni, D., Dynan, W.S. and Tijan, R. (1984) 
Nature 312, 409-413. 
[32] Nordheim, A. and Rich, A. (1983) Nature 303, 
674-679. 
[33] Karin, M., Haslinger, A., Holtgreve, H., Richards, 
R.I., Krauter, P., Westphal, H.M. and Beato, M. 
(1984) Nature 308, 513-519. 
[21] Takahashi, H., Hakamata, Y., Watanabe, Y., [34] Payvar, F., Wrange, O., Carlstedt-Duke, J., 
Kikuno, R., Miyata, T. and Numa, S. (1983) Okret, S., Gustafsson, J.-A. and Yamamoto, K.R. 
Nucleic Acids Res. 11, 6847-6857. (1981) Proc. Natl. Acad. Sci. USA 78, 6628-6632. 
[22] Nakanishi, S., Teranishi, Y., Watanabe, Y., [35] Scheidereit, C., Geisse, S., Westphal, H.M. and 
Notake, M., Noda, M., Kakidani, H., Jingami, H. Beato, M. (1983) Nature 304, 749-752. 
and Numa, S. (1981) Eur. J. Biochem. 115, [36] Cato, A.C.B., Geisse, S., Wenz, M., Westphal, 
429-438. H.M. and Beato, M. (1984) EMBO J. 3,2771-2778. 
[23] Notake, M., Tobimatsu, T., Watanabe, Y., Taka- 
hashi, H., Mishina, M. and Numa, S. (1983) FEBS 
Lett. 156, 67-71. 
58 
